Acquired
Novo Nordisk (Ozempic)
David Rosenthal
Yeah, super cool. We'll link to it in the sources. Yep. So eventually, after a couple years, she switches from the enzyme division to the diabetes business. And specifically, remember, this is not long after the genetic engineering revolution has happened. She gets put on the team that is screening new potential compounds that they could create for treatment of type 2 diabetes.
0
💬
0
Comments
Log in to comment.
There are no comments yet.